Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novogen Limited NVGN

Healthcare Drug Manufacturers - Specialty & Generic
"Novogen Ltd is a pharmaceutical drug development based on a simple benzopyran chemical structure. It is an emerging oncology-focused biotechnology company that develops anti-cancer drugs."

Recent & Breaking News (NDAQ:NVGN)

StockNewsNow.com Publishes New SNNLive Video Interview With Novogen Limited

Marketwired June 16, 2015

Novogen to Present at Bio International Convention Philadelphia 2015

PR Newswire June 12, 2015

Novogen Expands Board with Two New Appointments

PR Newswire June 2, 2015

Novogen Limited Announces Closing of Rights Issue Entitlement Offer and Notice of Shortfall

PR Newswire June 1, 2015

ATM Technology Extended with New Patent Lodgement

PR Newswire May 27, 2015

Novogen to Present at Brain Tumor Biotech Summit 2015

PR Newswire May 26, 2015

Novogen to Present at the 2015 Marcum Microcap Conference

PR Newswire May 25, 2015

Novogen to Present at Hong Kong Investor Conference

PR Newswire May 17, 2015

Anisina Confirmed as Effective Anti-Cancer Agent in Animal Studies

PR Newswire May 13, 2015

Novogen Completes the Private Placement of Equity

PR Newswire April 29, 2015

Novogen Regains Full Compliance with NASDAQ Listing Rule

PR Newswire April 27, 2015

Novogen Posts Details on Rights Issue Offering for Shareholders

PR Newswire April 27, 2015

Cantrixil Receives Orphan Drug Designation from FDA

PR Newswire April 21, 2015

Novogen Conducts Private Placement and Announces Rights Offering to Shareholders

PR Newswire April 20, 2015

Cantrixil Highly Successful in Preventing Growth of Chemo-Resistant Ovarian Cancer

PR Newswire April 20, 2015

Novogen Engages Leading US Investor Relations Firm

PR Newswire April 1, 2015

Yale University and Novogen Release Data on Cantrixil Mode of Action

PR Newswire March 29, 2015

Cantrixil Data to be Presented at Two Major Conferences

PR Newswire March 6, 2015

US Studies Confirm Ability of TRXE-009 to Kill Brain Cancer Stem Cells

PR Newswire March 4, 2015

Novogen to Present at AusBiotech "Broker Meets Biotech" Event

PR Newswire March 2, 2015